Professor Alastair Compston CBE
Addenbrooke’s Hospital, Cambridge
Alastair Compston is professor emeritus of neurology in the University of Cambridge. He was previously professor of neurology, University of Cambridge (1988-2015); consultant neurologist (1982-1987), and professor of neurology, University of Wales College of Medicine (1987-8); president of the European Neurological Society (2002-3) and the Association of British Neurologists (2009-2010; and editor of Brain, a journal of neurology (2004-13). He qualified in medicine from the Middlesex Hospital Medical School in 1971, and subsequently trained in neurology at the National Hospital and the Institute of Neurology, Queen Square. Alastair Compston is a Fellow of the Academy of Medical Sciences (1998); Foreign Member of the National Academy of Sciences of Germany (2008), Foreign Associate Member of the National Academy of Medicine of the USA (2012), and Fellow of the Royal Society (2016). He has been appointed Commander of the British Empire (2016). Alastair Compston’s research focuses on the clinical science of human demyelinating disease with contributions to the genetic epidemiology, immunology, neurobiology and treatment of multiple sclerosis. With others, he developed Alemtuzumab as a treatment for early relapsing-remitting disease. His research has been recognised by several international prizes and awards.
Professor Andrew Copp
Institute of Child Health, London
& 1979 Foulkes Fellow
Andrew Copp trained both as a scientist (PhD in experimental embryology, Oxford University, UK) and clinician (MD, Guy’s Hospital, UK), with the help of a Foulkes Foundation Fellowship (1979). He became a Fellow of the Royal College of Pathologists, UK in 2003. He worked as Research Fellow in Pediatrics at Stanford University, California, USA (1984-1986), Research Scientist at the ICRF Developmental Biology Unit, University of Oxford (1986-1992) and Senior Lecturer/Reader/Professor at the Institute of Child Health (1992-present). He is Honorary Consultant and Non-Executive Director of Great Ormond Street Hospital for Children, in London. He currently holds an endowed chair in Developmental Neurobiology and heads the Neural Development Unit at the UCL Institute of Child Health, London. His research centres upon the embryonic development of the nervous system, using mouse genetic models to study birth defects such as spina bifida. In 2000, he was elected Fellow of the Academy of Medical Sciences, and in 2003, he became Director of the UCL Institute of Child Health. He provides advice to the membership of the Foulkes Foundation in the area of academic paediatrics.
Professor Eileen Joyce
Institute of Neurology and Neurosurgery, London & 1980 Foulkes Fellow
Eileen Joyce is Professor of Neuropsychiatry at University College Institute of Neurology and an Honorary Consultant Psychiatrist at The National Hospital for Neurology and Neurosurgery. She received a BA in Experimental Psychology from the University of Cambridge (1975) where she subsequently completed a PhD in the behavioural neuroscience of dopamine. She qualified in medicine at the University of Cambridge (1981) and obtained training in clinical and academic psychiatry at The Maudsley Hospital and Institute of Psychiatry. She worked as a research associate at the National Institute on Alcohol Abuse and Alcoholism,USA(1989-1991) and at Imperial College London as a Senior Lecturer/Reader/Professor before taking up her current position in 2005. She is currently Chairman of the British Neuropsychiatry Association and is a member of the Executive Committee of the Section of Neuropsychiatry, Royal College of Psychiatrists. Her primary research interest is in the neural basis of schizophrenia focussing on cognitive dysfunction in the early stages of psychosis and how this relates to brain structural changes and clinical manifestations of the disorder.
Professor Denis Talbot (Chair)
Cancer Research U.K., Oxford
& 1978 Foulkes Fellow
Denis Talbot is Professor of Cancer Medicine at the University of Oxford and Consultant Medical Oncologist at the Oxford University Hospitals NHS Foundation Trust. He is head of the Oxford Neuroendocrine Tumour Centre, an ENETS European Centre of Excellence, and has expertise in thoracic oncology and drug development. Denis has published widely on early phase trials of agents targeting cell cycle regulatory proteins, growth factors, DNA repair, macrophage activation and apoptosis underpinned by translational research focused on proof of concept studies. Denis’ interests include research ethics, physician/patient communication skills and development of objective assessment tools for evaluating clinical skills. He is a member of the Lung Cancer CRG, Cancer Chemotherapy Information Group, BTOG Steering Committee, NCRI Lung Cancer Group and is Regional Specialty Advisor and past Chairman of the Specialist Advisory Committee for Medical Oncology and Central Oxford Research Ethics Committees. Denis has served on the ASCO Faculty, the Leukaemia and Lymphoma Research Fund Scientific and Medical Advisory Panel, Cancer Research UK Clinician Scientist Advisory Board and New Agents Committee. He chairs a number of Safety and Data Monitoring Committees for international lung cancer trials.
Professor John Williams CBE
University of Wales, Swansea
John Williams is Professor of Health Services Research at the School of Medicine, Swansea University, and Consultant Gastroenterologist at Abertawe Bro Morgannwg University NHS Trust. From 2002-07 he was Director of R&D for Wales, a post in which he established the Clinical Research Collaboration in Wales (CRC Cymru). His research interests include the development and evaluation of clinical interventions, and new models of service delivery, particularly in gastroenterology, and the greater involvement of patients in the process. He presently chairs a Board Subgroup for the UK Clinical Research Collaboration, to raise public awareness of the benefits of patient data being used for research, and is a member of the OSCHR e-Health Board. He has a long-standing interest in improving information systems that support patient care, and set-up and directs a Health Informatics Unit at the Royal College of Physicians of London. Health informatics is an emerging specialty of huge importance to the NHS as it strives to become better computerised and Professor Williams would be very happy to offer advice and support to any Fellows wishing to pursue a career in this direction.